Two initiatives bringing together the Oxford AHSN, NHS and industry to improve patient care are in the running for a national prize.
The projects are finalists in the HSJ Partnership Awards. The winners will be revealed on 20 March.
A collaboration with Bayer and Buckinghamshire Clinical Commissioning Group to cut the risk of stroke is shortlisted in the ‘Best Pharmaceutical Partnership with the NHS’ category. Read more here.
The Oxford AHSN’s work with Roche Diagnostics to introduce a new test for pre-eclampsia into maternity units is shortlisted in the ‘Best Healthcare Provider Partnership’ category.
Professor Gary Ford, Chief Executive of Oxford AHSN, said: “More accurate diagnosis brings many benefits – it reduces the need for admission for many pregnant women as well as indicating those who need closer monitoring. This is a powerful example of improved diagnostics leading to improved clinical care pathways.”
Chris Hudson, Director of Access and Innovation, Roche Diagnostics, said: “Working in partnership with the Oxford AHSN meant the right stakeholders were brought together with a clear plan developed to accelerate the adoption of this innovation, which can help patients receive the right level of care at the right time.”
Read more here.
HSJ editor Alastair McLellan said: “The HSJ Partnership Awards highlight the invaluable work performed by the organisations that work alongside the NHS to deliver first class patient care, shining a spotlight on their efforts which are often unseen but are essential. Each of the shortlisted organisations is delivering tangible benefits to NHS patients, clinicians and the facilities they use, making a real difference in these challenging economic times.”
- Read about all the AHSN finalists in the HSJ Partnership Awards here
- See the full HSJ Partnership Awards shortlist here